ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryGenevaKyowa Kirin Sàrl
Kyowa Kirin Sàrl Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Krystal Biotech, Inc. is the development and manufacture of pharmaceuticals, particularly biopharmaceuticals. The company focuses on the research and development of new therapeutics based on genetic and biotechnological methods. The company's products aim to treat various diseases and conditions, including rare genetic disorders.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered7
Gene Therapy for Dystrophic Epidermolysis Bullosa (VYJUVEK)
Gene therapy for dystrophic epidermolysis bullosa with VYJUVEK, the first and only redosable gene therapy for this disease, plus personalized patient support.
Gene Therapy Platform
Gene therapy platform based on a modified HSV-1 vector for redosable, non- or minimally invasive administration; supports development and commercialization of genetic medicines.
Oncology Gene Therapies
Oncology gene therapies with locally delivered immune-stimulating cytokines; a lead candidate uses a modified HSV-1 vector to deliver IL-12 and IL-2 to solid tumors.
Gene Therapies for Respiratory Diseases
Gene therapies for cystic fibrosis and alpha-1 antitrypsin deficiency, developed for pulmonary use in genetic diseases with high unmet need.
Gene Therapies for Ophthalmic Diseases
Gene therapies for ocular complications of dystrophic epidermolysis bullosa and other genetic eye diseases such as Stargardt disease.
Gene Therapies for Dermatologic Diseases
Gene therapies for genetic skin diseases such as autosomal recessive congenital ichthyosis and Netherton syndrome, complementing the approved skin platform.
Aesthetic Gene Therapies
Aesthetic gene therapies for age-related skin changes through targeted delivery of genes that boost collagen and elastin expression.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Kyowa Kirin Sàrl

Trust & reputation

ranQ Trust Score of Kyowa Kirin Sàrl: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Kyowa Kirin Sàrl has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Kyowa Kirin Sàrl scores 83.9 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.86.512%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Kyowa Kirin Sàrl scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Kyowa Kirin Sàrl scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Kyowa Kirin Sàrl reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Kyowa Kirin Sàrl has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Kyowa Kirin Sàrl in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Kyowa Kirin Sàrl by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Kyowa Kirin Sàrl to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Place des Alpes 4
1201 Geneva

At a glance

Legal form
Limited Liability Company
UID
CHE-350.938.341
Founded
2016 · 10 years
Last commercial register change
March 18, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    RP
    Rebio Pharma Sàrl
    Geneva
    AS
    Ageronix SA
    Carouge Ge
    CR
    CELL RECEPTOR SA
    Geneva
    UF
    Union for International Cancer Control (UICC)
    Geneva
    NS
    NovImmune SA
    Plan-Les-Ouates
    IS
    iOnctura SA
    Geneva
    SG
    SANOFI GESTION SA
    Vernier
    SS
    Skinpulse SARL
    Geneva